You just read:

The Global Clinical Next-Generation Sequencing (NGS) Market is Expected to Grow at a CAGR of 27%, from Nearly $3.2 Billion in 2017 to $10.5 Billion by 2022

News provided by

Research and Markets

Jul 06, 2017, 08:30 ET